Raimond Heukers
Utrecht, UT 3584CL, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
CXCR4-EGFR heteromers show ligand-dependent changes in conformation and signaling.
Journal: Cell chemical biology
Published: November 14, 2025
Anti-capsid nanobodies function as HIV-1 capsid inhibitors by intracellular capsid degradation.
Journal: Communications biology
Published: September 11, 2025
Plasma membrane rather than endosomal Gq signaling drives transcriptional activity by the viral chemokine receptor US28 in glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 11, 2025
Genetic Engineering of VHH Antibody Fragments for Efficient Site-Specific Conjugation to Polysaccharides.
Journal: Bioconjugate chemistry
Published: May 23, 2025
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.
Journal: bioRxiv : the preprint server for biology
Published: November 22, 2024
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.
Journal: Nature communications
Published: November 04, 2024
Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.
Journal: iScience
Published: April 29, 2024
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism.
Journal: Biochemical pharmacology
Published: April 10, 2024
Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity.
Journal: International journal of pharmaceutics
Published: March 19, 2024
TR-FRET between engineered nanobodies reveals the existence of endogenous CXCR4 oligomers.
Journal: Communications biology
Published: November 20, 2023
Last Updated: 09/26/2026